All Stories

  1. Physiological monitoring in the complex multimorbid heart failure patient - Conclusions

    Article • European Heart Journal Supplements, December 2019, Oxford University Press (OUP)

    Michael Böhm

  2. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk

    Article • European Heart Journal, March 2019, Oxford University Press (OUP)

    Michael Böhm

  3. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial

    Article • European Heart Journal, January 2019, Oxford University Press (OUP)

    Michael Böhm

  4. Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials

    Article • European Heart Journal, December 2018, Oxford University Press (OUP)

    Michael Böhm

  5. Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk

    Article • Patient Preference and Adherence, December 2018, Dove Medical Press

    Michael Böhm, Prof. Dr. Martin Schulz, Dr Felix Mahfoud

  6. Response to “Clinical Factors and Rate of Cough During Angiotensin-Converting Enzyme Inhibitor Treatment”

    Article • Clinical Pharmacology & Therapeutics, September 2018, Wiley

    Michael Böhm, Dr. Davor Vukadinovic

  7. Response to “Discontinuation of Angiotensin Converting Enzyme Inhibitors Due to Dry Cough: Incidence and Clinical Determinants”

    Article • Clinical Pharmacology & Therapeutics, July 2018, Wiley

    Michael Böhm, Dr. Davor Vukadinovic

  8. Mitral valve interventions in heart failure

    Article • ESC Heart Failure, April 2018, Wiley

    Michael Böhm

  9. Rate of Cough During Treatment With Angiotensin-Converting Enzyme Inhibitors: A Meta-Analysis of Randomized Placebo-Controlled Trials

    Article • Clinical Pharmacology & Therapeutics, February 2018, Wiley

    Michael Böhm, Dr. Davor Vukadinovic

  10. The association between different features of sleep-disordered breathing and blood pressure: A cross-sectional study

    Article • Journal of Clinical Hypertension, January 2018, Wiley

    Michael Böhm, Dr Mathias Baumert

  11. Duration of chronic heart failure affects outcomes with preserved effects of heart rate reduction with ivabradine: findings from SHIFT

    Article • European Journal of Heart Failure, October 2017, Wiley

    Michael Böhm

  12. Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats

    Article • Journal of the American Heart Association, September 2017, Wolters Kluwer Health

    Michael Böhm, Dr Jeroen M Hendriks

  13. Heart rate and its reduction in chronic heart failure and beyond

    Article • European Journal of Heart Failure, June 2017, Wiley

    Michael Böhm, Dr. Davor Vukadinovic

  14. Primum non nocere : the dangers of deferring heart failure therapy

    Article • European Journal of Heart Failure, June 2017, Wiley

    Michael Böhm

  15. Improvement in health-related quality of life after renal sympathetic denervation in real-world hypertensive patients: 12-month outcomes in the Global SYMPLICITY Registry

    Article • Journal of Clinical Hypertension, May 2017, Wiley

    Michael Böhm, giuseppe mancia

  16. Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF

    Article • European Heart Journal, February 2017, Oxford University Press (OUP)

    Michael Böhm, Professor john j mcmurray

  17. Heart rate: from heart failure to chronic diseases and cancer. Is there a role for supportive care by heart rate reduction?

    Article • European Journal of Heart Failure, December 2016, Wiley

    Michael Böhm

  18. Medication knowledge of patients hospitalized for heart failure at admission and after discharge

    Article • Patient Preference and Adherence, November 2016, Dove Medical Press

    Michael Böhm, Prof. Dr. Martin Schulz

  19. Heart rate as emerging risk indicator in stroke - the beat goes on

    Article • European Journal of Neurology, September 2016, Wiley

    Michael Böhm

  20. Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT

    Article • European Journal of Heart Failure, March 2016, Wiley

    Michael Böhm

  21. Low resting heart rates are associated with new-onset atrial fibrillation in patients with vascular disease: results of the ONTARGET/TRANSCEND studies

    Article • Journal of Internal Medicine, April 2015, Wiley

    Michael Böhm

  22. Twenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy

    Article • European Journal of Heart Failure, March 2015, Wiley

    Michael Böhm

  23. Prädiktiver Wert der Evaluation von Kongressabstracts für die Publikationshäufigkeit und -qualität: Analyse der Jahreskongresse der Deutschen Gesellschaft für Kardiologie

    Article • DMW - Deutsche Medizinische Wochenschrift, March 2015, Thieme Publishing Group

    Michael Böhm

  24. Too much is too much: evidence against dual RAAS inhibition in hypertensives with heart failure symptoms

    Article • European Heart Journal, February 2015, European Society of Cardiology

    Michael Böhm

  25. Resting heart rate is associated with renal disease outcomes in patients with vascular disease: results of the ONTARGET and TRANSCEND studies

    Article • Journal of Internal Medicine, December 2014, Wiley

    Michael Böhm

  26. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)

    Article • European Journal of Heart Failure, May 2014, Wiley

    Michael Böhm, Professor john j mcmurray

  27. Renal denervation and heart failure

    Article • European Journal of Heart Failure, March 2014, Wiley

    Dr Felix Mahfoud, Michael Böhm

  28. Effect of comorbidities on outcomes and angiotensin converting enzyme inhibitor effects in patients with predominantly left ventricular dysfunction and heart failure

    Article • European Journal of Heart Failure, January 2014, Wiley

    Michael Böhm

  29. Treating resistant hypertension: role of renal denervation

    Article • Integrated Blood Pressure Control, September 2013, Taylor & Francis

    Michael Böhm, Dr Felix Mahfoud

  30. Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease

    Article • American Heart Journal, August 2013, Elsevier

    Michael Böhm, Professor Ulrich Laufs

  31. Cardiovascular outcomes with angiotensin II receptor blockers: clinical implications of recent trials

    Article • Vascular Health and Risk Management, June 2011, Taylor & Francis

    Michael Böhm